TITLE

C-kit and PDGFRA gene mutations in triple negative breast cancer

AUTHOR(S)
Yun Zhu; Yan Wang; Bing Guan; Qiu Rao; Jiandong Wang; Henghui Ma; Zhihong Zhang; Xiaojun Zhou
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4280
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436153

 

Related Articles

  • C-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? Carvalho, S.; e Silva, A. O.; Milanezi, F.; Ricardo, S.; Leitão, D.; Amendoeira, I.; Schmitt, F. C. // Journal of Clinical Pathology;Oct2004, Vol. 57 Issue 10, p1075 

    Aim: To study the immunoexpression and mutational status of c-KIT and PDGFRA in a series of benign and malignant phyllodes tumours of the breast. Material/methods: Nineteen phyllodes tumours (13 benign and six malignant) were analysed by immunohistochemistry for the expression of c-KIT and...

  • Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China. Wen-Ming Cao; Yun Gao; Xiao-Jia Wang // Breast Cancer Research;Aug2015, Vol. 17 Issue 1, p1 

    A letter to the editor is presented in response to the article "Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy," by Y. H. Teng and colleagues in the 2011 issue.

  • Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. Domagala, Pawel; Jakubowska, Anna; Jaworska-Bieniek, Katarzyna; Kaczmarek, Katarzyna; Durda, Katarzyna; Kurlapska, Agnieszka; Cybulski, Cezary; Lubinski, Jan // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Purpose: This study sought to assess the prevalence of common germline mutations in several genes engaged in the repair of DNA double-strand break by homologous recombination in patients with triple-negative breast cancers and hereditary non-triple-negative breast cancers. Tumors deficient in...

  • Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy. Peddi, Parvin F.; Ellis, Matthew J.; Ma, Cynthia // International Journal of Breast Cancer;2012, p1 

    Triple negative breast cancer is an aggressive form of breast cancer with limited treatment options and is without proven targeted therapy. Understanding the molecular basis of triple negative breast cancer is crucial for effective new drug development. Recent genomewide gene expression and DNA...

  • Molecular Mechanism and Targeted Therapy Options of Triple-Negative (ER, PgR, HER-2/neu) Breast Cancer: Review. Kandula, Mahesh; Kumar Ch, Kalyan; Raju YS, Ammi // World Journal of Oncology;2013, Vol. 4 Issue 3, p137 

    Tripple negative breast cancer (TNBC) accounts for approximately 15% of breast cancers. It is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER-2 Over expression. Expression of ER, PR and HER-2 plays an important role in therapeutic assessment of patients with...

  • MOLECULAR BIOLOGICAL PECULIARITIES OF "TRIPLE NEGATIVE" BREAST CANCER. Yessentayeva, Suriya; Chichua, Nino; Khamidullina, Galina; Sreda, Yelena; Smagulova, Kaldigul; Turesheva, Aliya; Mussakhanova, Zhanna; Kozhakhmetov, Bakir; Abdulakhanova, Roza; Tleugabilova, Gulnar // Medical & Health Science Journal;Apr2010, Vol. 1 Issue 1, p26 

    The examination of 31 cases of breast cancer with "triple negative" status has observed biological appearances including grade of histologic tumor (G), indice of proliferation (ki67), expression of mutated protein ?53, protein E-kadherin, vimentin and c-kit. The observation has revealed a...

  • Unique Profile of Adenoid Cystic Carcinoma: A Triple Negative Breast Tumor With Paradoxical Features, a Case Report and Review of Literature. Jaggessarsingh, Dana; Muram-Zborovski, Talia M.; Bemis, Lynne; Robinson, William A.; Finlayson, Christina; Singh, Meenakshi // Laboratory Medicine;Dec2010, Vol. 41 Issue 12, p713 

    Adenoid cystic carcinomas (ACC) of the breast are uncommon tumors that are not well characterized and have seemingly paradoxical features. We report the case of a deceptively well circumscribed adenoid cystic carcinoma with multiple additional foci of invasive tumor. Immunohistochemical studies...

  • Sisters Act.  // Allure;Oct2013, Vol. 23 Issue 10, p190 

    The article presents information on sisters Jennifer Arnold and Kristen Worden of which, one was identified with breast cancer and other was identified to carry the gene mutation that causes cancer. It informs that Worden was identified with triple-negative breast cancer is often found in...

  • The Observatory. Cancer.  // MLO: Medical Laboratory Observer;Jan2015, Vol. 47 Issue 1, p6 

    The article discusses a study that sequenced the deoxyribonucleic acid (DNA) of patients with triple-negative breast cancer (BRCA), its findings about deleterious mutations and recommendations that genetic testing should be conducted for predisposition gene mutations in BRCA1 and BRCA2 as...

  • Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. Tadashi Terada // Medical Oncology;Jun2009, Vol. 26 Issue 2, p233 

    Abstract  The author reports a rare case of primary large cystic extragastrointestinal stromal tumor (eGIST) of the transverse mesocolon with genetic analyses of the c-kit and platelet-derived growth factor receptor-α (PDGFRA) genes. A 78-year-old man was found to have a large cystic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics